Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Tanshinone IIA Sulfonate in Pulmonary Hypertension
NCT01637675Phase 3Unknown
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- May 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium tanshinone IIA sulfonate in pulmonary hypertension (PH), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Status: unknown.
02
Drugs
sodium tanshinone IIA sulfonate
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01637675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01637675.